Estimating disease severity of Omicron and Delta SARS-CoV-2 infections

Nat Rev Immunol. 2022 May;22(5):267-269. doi: 10.1038/s41577-022-00720-5.

Alex Sigal^{1

2

3

4}, Ron Milo⁵, Waasila Jassat^{6

7}

¹ Africa Health Research Institute, Durban, South Africa. alex.sigal@ahri.org.
² School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa. alex.sigal@ahri.org.
³ Max Planck Institute for Infection Biology, Berlin, Germany. alex.sigal@ahri.org.
⁴ Centre for the AIDS Programme of Research in South Africa, Durban, South Africa. alex.sigal@ahri.org.
⁵ Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel.
⁶ Division of Public Health Surveillance and Response, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
⁷ Right to Care, Centurion, South Africa.

No abstract available

MeSH terms